Chinese government enforces biggest crackdown on offshore trading in decades Ivar AI

Diariodocentrodomundo.com.br

EUA atacam Irã após derrubada de helicóptero militar

tagesschau.de

US-Armee meldet Angriffe auf Iran nach Vorwurf des Helikopter-Abschusses

GlobeNewswire

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

Yahoo Entertainment

美軍空襲伊朗反擊直升機事件中東局勢動盪衝擊油市

BusinessLine

US inflation climbs to 4.2% and hits 3-year high amid rising fuel costs

Diariobitcoin.com

Binance Research: el mercado de activos tokenizados creció un 589% en apenas un año

Crypto Briefing

US military launches airstrikes against Iran after helicopter downing near Strait of Hormuz

PRNewswire

Oracle Announces Record Q4 and FY 2026 Results Driven by Cloud Infrastructure & Cloud Applications

Orf.at

US-Armee meldet neue Angriffe auf Iran

Crypto Briefing

US Army helicopter shot down by Iran near Strait of Hormuz, Trump confirms

Foreign Policy

Trump Started a War He Can’t Control

Digitimes

AI demand is turning memory chips into rationed assets, Morgan Stanley says

PRNewswire

TeamSystem finaliza su plan de inversión en IA de 250 millones de dólares un año antes de lo previsto

Globo

Após Anthropic, OpenAI, do ChatGPT, entra com pedido de IPO nos EUA

Crypto Briefing

House passes sanctions on Russia and aid for Ukraine amid Senate uncertainty

CNN

OpenAI files for IPO | CNN Business

Yahoo Entertainment

大股災！台股早盤崩跌2281點　台積電開盤價曝光

Crypto Briefing

American Bitcoin grows BTC balance sheet to 7,021 coins, cites 50% mining margin

Mediaite

NEW: Trump Bombs Iran Second Night In a Row As Negotiations Falter

The Times of India

U.S. spending on rebuilding nuclear arsenal more than all other nuclear states combined including China, Russia

Businessam.be

Italiaanse bank Intesa Sanpaolo kan dankzij overname op één na grootste bank van Europa worden

Crypto Briefing

Cynthia Lummis calls for US to accumulate Bitcoin openly while other nations buy quietly

$Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire$

GlobeNewswire

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire